survival (n = 32) | non-survival (n = 8) | p | |
---|---|---|---|
On admission | |||
CK-MB (U/L) | 101 (49.3, 109.5) | 226.8 (57, 290.3) | 0.06 |
cTnI (ug/L) | 1.1 (0.5, 1.3) | 2.1 (0.9, 3.4) | 0.052 |
Scr (umol/L) | 70.2 (37, 70) | 120.1 (56.8, 182.8) | 0.016 |
AST(U/L) | 287.3 (89, 424.5) | 941.6 (102, 2006.8) | 0.12 |
ALT(U/L) | 150.7 (25, 210) | 711.8 (59.5, 1330.8) | 0.31 |
Lactate (mmol/L) | 4.8 (2.5, 6.4) | 7 (4.1, 9.1) | 0.048 |
NT-proBNP (pg/mL) | 24,553.2(4282.5, 27328.8) | 18,375.3 (5156.5, 34480.3) | 0.477 |
Peak levels | |||
CK-MB (U/L) | 178 (50, 160.3) | 1004.8 (264.8, 902.8) | < 0.001 |
cTnI (ug/L | 1.8 (0.7, 2.3) | 4.4 (2.0, 5.5) | 0.006 |
Scr (umol/L) | 93.8 (49, 86.5) | 311.6 (122.8, 260.8) | < 0.001 |
AST(U/L) | 914.4 (116, 1122.5) | 4124 (1144, 4526.5) | 0.003 |
ALT(U/L) | 764.4 (47.5, 909.8) | 2448.8 (347, 3764.3) | 0.015 |
Lactate (mmol/L) | 7.8 (4.8, 11) | 13.6 (11.3, 15) | 0.002 |
NT-proBNP (pg/mL) | 19,856.1(9297.5, 34378.3) | 30,211 (23460.5, 35000) | 0.014 |